Literature DB >> 24757944

The role of nanotechnology in combating multi-drug resistant bacteria.

Rajni Singh, M S Smitha, Surinder P Singh.   

Abstract

The development of antibiotics has played a significant role in combating the dreaded infectious disease such as tuberculosis, pneumonia, typhoid fever and meningitis in 20th century. However, the improper use of antibiotics led to the development of multidrug resistance (MDR) in microbial flora raising a global public health concern of 21st century. This unforeseen threat demands the development of new drugs and strategies for combating antibiotic resistance shown by many microbial species. Recent developments in nanotechnology to engineer nanoparticles with desired physicochemical properties have been projected as a new line of defense against MDR micro-organism. In this review, we summarized and discussed the recent development demonstrating the potential of nanomaterials to evade the MDR. Nanoparticles have shown effective antimicrobial activity against MDR bacteria, such as Acinetobacter baumanii, Pseudomonas aeruginosa, Klebsiella pneumoniae, Mycobacterium tuberculosis, vancomycin resistant enterococci, methicillin-resistant Staphylococcus aureus and others. Furthermore, new strategies like combination of radiation and drugs with nanoparticle that are being explored to potentiate the effectiveness against MDR bacteria have also been summarized.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24757944     DOI: 10.1166/jnn.2014.9527

Source DB:  PubMed          Journal:  J Nanosci Nanotechnol        ISSN: 1533-4880


  29 in total

1.  Nanomedicine in the Management of Microbial Infection - Overview and Perspectives.

Authors:  Xi Zhu; Aleksandar F Radovic-Moreno; Jun Wu; Robert Langer; Jinjun Shi
Journal:  Nano Today       Date:  2014-08-01       Impact factor: 20.722

Review 2.  Antibiotic stewardship programmes in intensive care units: Why, how, and where are they leading us.

Authors:  Yu-Zhi Zhang; Suveer Singh
Journal:  World J Crit Care Med       Date:  2015-02-04

3.  Evaluation of antimicrobial properties of a novel synthesized nanometric delafossite.

Authors:  Mohsen A Sayed; Asmaa A H El-Bassuony; H K Abdelsalam
Journal:  Braz J Microbiol       Date:  2020-08-21       Impact factor: 2.476

4.  Evaluation of photodynamic therapy effect along with colistin on pandrug-resistant Acinetobacter baumannii.

Authors:  Maryam Pourhajibagher; Hosein Kazemian; Nasim Chiniforush; Abbas Bahador
Journal:  Laser Ther       Date:  2017-06-30

Review 5.  Multi-functionalized nanocarriers targeting bacterial reservoirs to overcome challenges of multi drug-resistance.

Authors:  Maria Hassan Kiani; Muhammad Imran; Abida Raza; Gul Shahnaz
Journal:  Daru       Date:  2020-03-19       Impact factor: 3.117

6.  Sugar-Grafted Cyclodextrin Nanocarrier as a "Trojan Horse" for Potentiating Antibiotic Activity.

Authors:  Min Li; Koon Gee Neoh; Liqun Xu; Liang Yuan; David Tai Leong; En-Tang Kang; Kim Lee Chua; Li Yang Hsu
Journal:  Pharm Res       Date:  2016-01-20       Impact factor: 4.200

Review 7.  Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections.

Authors:  Jessa Marie V Makabenta; Ahmed Nabawy; Cheng-Hsuan Li; Suzannah Schmidt-Malan; Robin Patel; Vincent M Rotello
Journal:  Nat Rev Microbiol       Date:  2020-08-19       Impact factor: 60.633

8.  Ciprofloxacin Functionalized Biogenic Gold Nanoflowers as Nanoantibiotics Against Pathogenic Bacterial Strains.

Authors:  Smitha Mony Sreedharan; Rajni Singh
Journal:  Int J Nanomedicine       Date:  2019-12-17

Review 9.  Novel approaches for the treatment of methicillin-resistant Staphylococcus aureus: Using nanoparticles to overcome multidrug resistance.

Authors:  Kushal Vanamala; Katyayani Tatiparti; Ketki Bhise; Samaresh Sau; Marc H Scheetz; Michael J Rybak; David Andes; Arun K Iyer
Journal:  Drug Discov Today       Date:  2020-10-20       Impact factor: 7.851

10.  Staphylococcus aureus and MRSA Growth and Biofilm Formation after Treatment with Antibiotics and SeNPs.

Authors:  Kristyna Cihalova; Dagmar Chudobova; Petr Michalek; Amitava Moulick; Roman Guran; Pavel Kopel; Vojtech Adam; Rene Kizek
Journal:  Int J Mol Sci       Date:  2015-10-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.